Kim, K. H., Greenfield, W. W., Cannon, M. J., Coleman, H. N., Spencer, H. J., & Nakagawa, M. (2011). CD4+ T-Cell Response Against Human Papillomavirus Type 16 E6 Protein Is Associated with A Favorable Clinical Trend.

Kim, Kevin H., William W. Greenfield, Martin J. Cannon, Hannah N. Coleman, Horace J. Spencer, und Mayumi Nakagawa. CD4+ T-Cell Response Against Human Papillomavirus Type 16 E6 Protein Is Associated With A Favorable Clinical Trend. 2011.

Kim, Kevin H., et al. CD4+ T-Cell Response Against Human Papillomavirus Type 16 E6 Protein Is Associated With A Favorable Clinical Trend. 2011.